Moffitt Cancer Center Supports Personalized Medicine With Oracle Health Sciences Technology
See on Scoop.it - Analytics & Social media impact on Healthcare— Moffitt Cancer Center has gone live with its next-generation health
and research informatics (HRI) platform, built on Oracle Health
Sciences solutions. In early deployment, the new platform enables
Moffitt to accelerate clinical trial patient recruitment and advance
personalized medicine.
— The new informatics environment, built using Oracle Health Sciences
Enterprise Healthcare Analytics, Oracle Healthcare Master Person
Index, Oracle Fusion Middleware, and Oracle Database 11g, supports
Moffitt’s Total Cancer Care(TM) program by generating new
intelligence from existing systems.
— Securely synthesizing data from numerous clinical sources, a
state-of-the-art biobank, and patient-reported information, the Oracle
solution delivers rapid and accurate analysis that is helping to
reveal new insight around treatment effectiveness at an individual
level, with the goal of advancing personalized medicine initiatives.
— Since deploying the solution, Moffitt has experienced an increase in
the number of data requests from researchers and has streamlined
patient cohort identification for cancer treatment studies.
— Moffitt has automated clinical trial candidate identification,
eliminating a manual effort that required months of reviewing paper
and electronic data sources to identify the best candidates. Today,
researchers can access information on-demand, from their desktops to
find de-identified patient cohorts within minutes.
— Increasing the volume of data available for analysis will enable
Moffitt to identify and validate targeted patient populations for
cancer trials and, thereby, improve clinical trial efficiency and
productivity.
— The HRI platform sets the stage for developing a true Learning
Healthcare System. Data collected electronically at the point-of-care
can be made available for advanced research studies. Discoveries from
this research will ultimately be reincorporated into clinical decision
support tools that facilitate the delivery of individualized and
personalized patient care.
Supporting Quotes
— “Oracle is honored to play a foundational role in Moffitt Cancer
Center’s new health and research informatics platform,” said Neil de
Crescenzo, senior vice president and general manager, Oracle Health
Sciences. “Even in its early deployment, the platform shows tremendous
potential to help Moffitt Cancer Center advance its personalized
medicine initiative and improve outcomes. Moffitt’s work in this area
is a testament to the power of IT to drive innovation in healthcare.”
— “With our health and research informatics platform built on Oracle
solutions, we’ve improved our ability to standardize, aggregate, and
analyze internal and external data — ranging in granularity from
molecular information to patient outcomes — to advance our Total
Cancer Care initiative,” said Mark Hulse, R.N., vice president of
information technology and chief information officer, Moffitt Cancer
Center. “In addition, our ability to use the platform to quickly
identify possible candidates for clinical trials is an important first
win.”
Supporting Resources
— Oracle in Health Sciences
— Follow Oracle Health Sciences on Twitter
— Join the Oracle Health Sciences Community on Facebook
— Oracle Health Sciences on YouTube
— Press Release: Moffitt Cancer Center and Oracle Health Sciences to
Develop Next-Generation Health and Research Informatics System
About Oracle Oracle engineers hardware and software to work together in the cloud and in your data center. .
About Oracle in Industries Oracle industry solutions leverage the company’s best-in-class portfolio of products to address complex business processes relevant to health sciences, helping speed time to market, reduce costs, and gain a competitive edge.
Located in Tampa, Moffitt Cancer Center is the only Florida-based National Cancer Institute Comprehensive Cancer Center, a designation that recognizes Moffitt’s excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt has 14 affiliates in Florida, one in Georgia, one in Pennsylvania and two in Puerto Rico. Moffitt is also a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer.
Trademark Oracle is a registered trademark of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.
See on marketwatch.com